We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$10.6B
AUM Growth
-$1.52B
Cap. Flow
+$47.1M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$66.2M
2
MTB icon
M&T Bank
MTB
+$43.8M
3
BKR icon
Baker Hughes
BKR
+$38.3M
4
ORCL icon
Oracle
ORCL
+$36.5M
5
CDK
CDK Global, Inc.
CDK
+$35.6M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 17.05%
3 Financials 15.67%
4 Industrials 13.84%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
101
Agilent Technologies
A
$39.7B
$37.6M 0.36%
316,763
+251,971
+389% +$31M
EL icon
102
Estee Lauder
EL
$30.7B
$37.5M 0.35%
147,125
+4,541
+3% +$1.15M
AVY icon
103
Avery Dennison
AVY
$12.9B
$37.3M 0.35%
230,310
+7,534
+3% +$1.29M
AZPN
104
DELISTED
Aspen Technology Inc
AZPN
$37.1M 0.35%
+202,196
New +$36M
ATO icon
105
Atmos Energy
ATO
$29.9B
$36.9M 0.35%
329,400
-34,705
-10% -$3.98M
ORCL icon
106
Oracle
ORCL
$346B
$36.4M 0.34%
521,571
-497,940
-49% -$36.5M
PKG icon
107
Packaging Corp of America
PKG
$22.6B
$36.1M 0.34%
262,807
+7,217
+3% +$1.12M
GMED icon
108
Globus Medical
GMED
$10.9B
$36.1M 0.34%
642,240
+6,024
+0.9% +$396K
COLD icon
109
Americold
COLD
$4.17B
$35.5M 0.34%
1,182,945
+1,168,320
+7,989% +$32.5M
LSTR icon
110
Landstar System
LSTR
$6.29B
$35.4M 0.33%
243,710
+1,070
+0.4% +$159K
CRVL icon
111
CorVel
CRVL
$3.14B
$35.1M 0.33%
715,203
-107,280
-13% -$5.52M
MCO icon
112
Moody's
MCO
$83.9B
$33.8M 0.32%
124,420
-31,313
-20% -$9.37M
PG icon
113
Procter & Gamble
PG
$347B
$33.7M 0.32%
234,541
-536
-0.2% -$80.6K
MTX icon
114
Minerals Technologies
MTX
$2.33B
$33.7M 0.32%
549,441
+108,171
+25% +$6.91M
CINF icon
115
Cincinnati Financial
CINF
$28B
$33.6M 0.32%
282,761
-9,440
-3% -$1.2M
TRMB icon
116
Trimble
TRMB
$13.6B
$33.5M 0.32%
575,327
+160,291
+39% +$10.5M
CATY icon
117
Cathay General Bancorp
CATY
$4.25B
$33.3M 0.32%
851,437
+186,354
+28% +$7.61M
SLB icon
118
SLB Ltd
SLB
$74.2B
$33.1M 0.31%
926,811
+285,786
+45% +$11.9M
AOS icon
119
A.O. Smith
AOS
$8.82B
$33M 0.31%
603,514
+25,386
+4% +$1.52M
AFG icon
120
American Financial Group
AFG
$12B
$32.7M 0.31%
235,262
+4,880
+2% +$686K
MZTI
121
The Marzetti Company
MZTI
$3.02B
$31.9M 0.3%
247,661
+1,682
+0.7% +$230K
SXT icon
122
Sensient Technologies
SXT
$5.3B
$31.4M 0.3%
389,562
+3,364
+0.9% +$279K
AXP icon
123
American Express
AXP
$227B
$31.3M 0.3%
225,799
-5,663
-2% -$935K
JKHY icon
124
Jack Henry & Associates
JKHY
$11.2B
$31.3M 0.3%
173,698
+8,474
+5% +$1.59M
CORT icon
125
Corcept Therapeutics
CORT
$10.1B
$31.2M 0.29%
1,311,038
+12,226
+0.9% +$266K

Similar funds

Boston Trust Walden's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
  • Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
  • Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
  • Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
  • Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.